The updated guidelines note that patients with stage IV NSCLC who have EGFR exon 19 deletions or exon 21 L858R substitutions can receive osimertinib plus platinum doublet chemotherapy or amivantamab ...
Life-threatening lung cancer has taught me many valuable lessons and made my new normal so fulfilling. My life has changed ...
FDG PET-derived imaging biomarkers of airway inflammation and their clinical associations in patients with non-small cell ...
A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.
The study authors say their findings argue for careful reading of CT scans done for other reasons that may reveal the ...
Among patients with resectable non-small cell lung cancer, Opdivo plus Yervoy has displayed potential long-term clinical ...
3d
Agilent Technologies (NYSE:A) recently achieved EU IVDR approval for two new indications of its PD-L1 IHC 28-8 pharmDx kit, expanding treatment options for early-stage NSCLC and advanced melanoma.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback